BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotté P, Lerebours E, Michel P. Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer. Am J Gastroenterology 2007;102:2557-63. [DOI: 10.1111/j.1572-0241.2007.01437.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Kim SR, Chung SJ, Yoo S. Factors contributing to malnutrition in patients with Parkinson's disease: Malnutrition in patients with PD. International Journal of Nursing Practice 2016;22:129-37. [DOI: 10.1111/ijn.12377] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
2 Skipworth J, Foster J, Raptis D, Hughes F. The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma. Dis Esophagus 2009;22:559-63. [PMID: 19222536 DOI: 10.1111/j.1442-2050.2009.00939.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
3 Takeda K, Umezawa R, Takahashi N, Matsushita H, Kozumi M, Ishikawa Y, Yamamoto T, Takeda K, Jingu K. Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancer. Esophagus 2018;15:190-7. [DOI: 10.1007/s10388-018-0612-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
4 Cong L, Hu L. The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2017;46:75-79. [PMID: 28268208 DOI: 10.1016/j.intimp.2017.02.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Furness K, Silvers MA, Savva J, Huggins CE, Truby H, Haines T. Long-term follow-up of the potential benefits of early nutritional intervention in adults with upper gastrointestinal cancer: a pilot randomised trial. Support Care Cancer 2017;25:3587-93. [PMID: 28612158 DOI: 10.1007/s00520-017-3789-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
6 Chen F, Fang J, Wang H, Song T, Zhu W, Wu M, Wu Y. Effects of nutritional support on short-term clinical outcomes and immune response in unresectable locally advanced oesophageal squamous cell carcinoma. Eur J Cancer Care (Engl) 2018;27:e12818. [PMID: 29345017 DOI: 10.1111/ecc.12818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Conroy T, Yataghène Y, Etienne PL, Michel P, Senellart H, Raoul JL, Mineur L, Rives M, Mirabel X, Lamezec B. Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer. Br J Cancer. 2010;103:1349-1355. [PMID: 20940718 DOI: 10.1038/sj.bjc.6605943] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
8 Pang Q, Wei X, Zhang W, Zhang T, Chen X, Dong J, Wei H, Er P, Zhao J, Han D, Guo Z, Lei T, Du Q, Guan Y, Wang J, Zhao L, Wang J, Yuan Z, Song Y, Liu N, Wang P. Annual report of the esophageal cancer radiation group of the Department of Radiotherapy, Tianjin Medical University Cancer Institute & Hospital. Ann Transl Med 2020;8:1156. [PMID: 33241005 DOI: 10.21037/atm-20-4064] [Reference Citation Analysis]
9 Vendrely V, Launay V, Najah H, Smith D, Collet D, Gronnier C. Prognostic factors in esophageal cancer treated with curative intent. Dig Liver Dis 2018;50:991-6. [PMID: 30166221 DOI: 10.1016/j.dld.2018.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
10 Bozzetti F. Nutritional interventions in elderly gastrointestinal cancer patients: the evidence from randomized controlled trials. Support Care Cancer 2019;27:721-7. [PMID: 30413927 DOI: 10.1007/s00520-018-4532-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Lu J, Cao LL, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Lin M, Tu RH, Huang CM, Zheng CH. Significance of Preoperative Systemic Immune Score for Stage I Gastric Cancer Patients. Gastroenterol Res Pract 2018;2018:3249436. [PMID: 30116261 DOI: 10.1155/2018/3249436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Siersema PD, van Hillegersberg R. Treatment of locally advanced esophageal cancer with surgery and chemoradiation. Curr Opin Gastroenterol 2008;24:535-40. [PMID: 18622172 DOI: 10.1097/MOG.0b013e3283025ca2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
13 Conroy T. [Clinical case: should esophageal cancers still be operated on?]. Gastroenterol Clin Biol 2009;33:285-8. [PMID: 19304427 DOI: 10.1016/j.gcb.2009.02.013] [Reference Citation Analysis]
14 Ashby D, Choi P, Bloom S. Gut hormones and the treatment of disease cachexia: Nutrition Society and BAPEN Medical Symposium on ‘Nutrition support in cancer therapy’. Proc Nutr Soc 2008;67:263-9. [DOI: 10.1017/s0029665108007143] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Nasrah R, Kanbalian M, Van Der Borch C, Swinton N, Wing S, Jagoe R. Defining the role of dietary intake in determining weight change in patients with cancer cachexia. Clinical Nutrition 2018;37:235-41. [DOI: 10.1016/j.clnu.2016.12.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
16 Michel P, Breysacher G, Mornex F, Seitz JF, Pere-Verge D, Martel-Lafay I, Faroux R, Chapet S, Sobhani I, Pezet D. Feasibility of preoperative and postoperative chemoradiotherapy in gastric adenocarcinoma. Two phase II studies done in parallel. Fédération Francophone de Cancérologie Digestive 0308. Eur J Cancer. 2014;50:1076-1083. [PMID: 24433843 DOI: 10.1016/j.ejca.2013.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
17 Ryan AM, Sullivan ES. Impact of musculoskeletal degradation on cancer outcomes and strategies for management in clinical practice. Proc Nutr Soc 2021;80:73-91. [PMID: 32981540 DOI: 10.1017/S0029665120007855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Mori M, Doki Y. Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med 2011;2:879-85. [PMID: 22977592 DOI: 10.3892/etm.2011.308] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
19 Lyu J, Li T, Xie C, Li J, Xing L, Zhang X, Shen L, Zhao K, Zhao R, Yang D, Li X, Zhu S, Sun W, Shi H; China Society for Nutritional Oncology. Enteral nutrition in esophageal cancer patients treated with radiotherapy: a Chinese expert consensus 2018. Future Oncol 2019;15:517-31. [PMID: 30457348 DOI: 10.2217/fon-2018-0697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Huang TT, Li SH, Chen YH, Lu HI, Lo CM, Fang FM, Chou SY, Chiu YC, Chou YP, Wang YM. Definitive chemoradiotherapy for clinical T4b esophageal cancer - Treatment outcomes, failure patterns, and prognostic factors. Radiother Oncol 2021;157:56-62. [PMID: 33482233 DOI: 10.1016/j.radonc.2021.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Liu J, Wang F, Li S, Huang W, Jia Y, Wei C. The prognostic significance of preoperative serum albumin in urothelial carcinoma: a systematic review and meta-analysis. Biosci Rep 2018;38:BSR20180214. [PMID: 29685957 DOI: 10.1042/BSR20180214] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
22 Langer FB, Schoppmann SF, Prager G, Tomaselli F, Pluschnig U, Hejna M, Schmid R, Zacherl J. Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol. 2010;17:470-475. [PMID: 19859771 DOI: 10.1245/s10434-009-0760-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
23 Clavier JB, Antoni D, Atlani D, Ben Abdelghani M, Schumacher C, Dufour P, Kurtz JE, Noel G. Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer. Dis Esophagus 2014;27:560-7. [PMID: 23106980 DOI: 10.1111/j.1442-2050.2012.01441.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
24 Movahed S, Norouzy A, Ghanbari-Motlagh A, Eslami S, Khadem-Rezaiyan M, Emadzadeh M, Nematy M, Ghayour-Mobarhan M, Varshoee Tabrizi F, Bozzetti F, Seilanian Toussi M. Nutritional Status in Patients with Esophageal Cancer Receiving Chemoradiation and Assessing the Efficacy of Usual Care for Nutritional Managements. Asian Pac J Cancer Prev 2020;21:2315-23. [PMID: 32856860 DOI: 10.31557/APJCP.2020.21.8.2315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Park JW, Kim JH, Choi EK, Lee SW, Yoon SM, Song SY, Lee YS, Kim SB, Park SI, Ahn SD. Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 2011;81:691-7. [PMID: 20888705 DOI: 10.1016/j.ijrobp.2010.06.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fakhrian K, Ordu AD, Nieder C, Lordick F, Kup PG, Theisen J, Combs SE, Geinitz H. Outcomes of patients with squamous cell carcinoma of esophagus who did not receive surgical resection after neoadjuvant radiochemotherapy. Tumori 2015;101:263-7. [PMID: 25908044 DOI: 10.5301/tj.5000266] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Park JW, Lee SW. Clinical outcomes of synchronous head and neck and esophageal cancer. Radiat Oncol J 2015;33:172-8. [PMID: 26484300 DOI: 10.3857/roj.2015.33.3.172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Isenring E, Zabel R, Bannister M, Brown T, Findlay M, Kiss N, Loeliger J, Johnstone C, Camilleri B, Davidson W, Hill J, Bauer J. Updated evidence-based practice guidelines for the nutritional management of patients receiving radiation therapy and/or chemotherapy: 2012 Radiation therapy and/or chemotherapy nutrition guidelines. Nutrition & Dietetics 2013;70:312-24. [DOI: 10.1111/1747-0080.12013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
29 Adenis A, Tresch E, Dewas S, Romano O, Messager M, Amela E, Clisant S, Kramar A, Mariette C, Mirabel X. Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome. BMC Cancer 2013;13:413. [PMID: 24010566 DOI: 10.1186/1471-2407-13-413] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
30 Bozzetti F, Zupec-kania B. Toward a cancer-specific diet. Clinical Nutrition 2016;35:1188-95. [DOI: 10.1016/j.clnu.2015.01.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
31 Sunde B, Ericson J, Kumagai K, Lundell L, Tsai JA, Lindblad M, Rouvelas I, Friesland S, Wang N, Nilsson M. Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction. Dis Esophagus 2016;29:442-7. [PMID: 25809837 DOI: 10.1111/dote.12352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
32 Seo SH, Kim SE, Kang YK, Ryoo BY, Ryu MH, Jeong JH, Kang SS, Yang M, Lee JE, Sung MK. Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients. BMC Cancer 2016;16:900. [PMID: 27863481 DOI: 10.1186/s12885-016-2934-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
33 Wang C, Lu M, Zhou T, Zhao S, Guan S. Intensity-modulated radiotherapy does not decrease the risk of malnutrition in esophageal cancer patients during radiotherapy compared to three-dimensional conformal radiation therapy. J Thorac Dis 2019;11:3721-31. [PMID: 31656644 DOI: 10.21037/jtd.2019.09.33] [Reference Citation Analysis]
34 Järvinen T, Ilonen I, Kauppi J, Salo J, Räsänen J. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol 2018;16:27. [PMID: 29433514 DOI: 10.1186/s12957-018-1327-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
35 Kim SH, Lee SM, Jeung HC, Lee IJ, Park JS, Song M, Lee DK, Lee SM. The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy. Nutrients 2019;11:E1145. [PMID: 31121926 DOI: 10.3390/nu11051145] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
36 Bozzetti F. Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Ann Oncol. 2017;28:2107-2118. [PMID: 28911059 DOI: 10.1093/annonc/mdx271] [Cited by in Crossref: 85] [Cited by in F6Publishing: 82] [Article Influence: 21.3] [Reference Citation Analysis]
37 Cushen SJ, Power DG, Ryan AM. Nutrition Assessment in Oncology. Topics in Clinical Nutrition 2015;30:103-19. [DOI: 10.1097/tin.0000000000000023] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
38 Nagaraja V, Cox MR, Eslick GD. Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. J Gastrointest Oncol 2014;5:119-26. [PMID: 24772340 DOI: 10.3978/j.issn.2078-6891.2014.007] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
39 Qin J, Zhu HD, Guo JH, Ni CF, Wu P, Xu H, Mao AW, Lu J, Su C, Teng GJ. Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis. Dis Esophagus 2019;32:doz012. [PMID: 30888392 DOI: 10.1093/dote/doz012] [Reference Citation Analysis]
40 Tougeron D, Richer JP, Silvain C. Management of esophageal adenocarcinoma. J Visc Surg. 2011;148:e161-e170. [PMID: 21715236 DOI: 10.1016/j.jviscsurg.2011.05.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
41 Langius JA, Twisk J, Kampman M, Doornaert P, Kramer MH, Weijs PJ, Leemans CR. Prediction model to predict critical weight loss in patients with head and neck cancer during (chemo)radiotherapy. Oral Oncology 2016;52:91-6. [DOI: 10.1016/j.oraloncology.2015.10.021] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
42 Cox S, Powell C, Carter B, Hurt C, Mukherjee S, Crosby TD. Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1. Br J Cancer 2016;115:172-7. [PMID: 27328311 DOI: 10.1038/bjc.2016.129] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
43 Joseph R, Laks S, Meyers M, McRee AJ. Multidisciplinary Approach to the Management of Esophageal Malignancies. World J Surg 2017;41:1726-33. [PMID: 28361298 DOI: 10.1007/s00268-017-4009-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Silvers MA, Savva J, Huggins CE, Truby H, Haines T. Potential benefits of early nutritional intervention in adults with upper gastrointestinal cancer: a pilot randomised trial. Support Care Cancer 2014;22:3035-44. [PMID: 24908429 DOI: 10.1007/s00520-014-2311-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
45 Otowa Y, Nakamura T, Takiguchi G, Tomono A, Yamamoto M, Kanaji S, Imanishi T, Suzuki S, Tanaka K, Itoh T, Kakeji Y. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer. Diseases of the Esophagus 2016;29:146-51. [DOI: 10.1111/dote.12316] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
46 Feng JF, Huang Y, Chen QX. A new inflammation index is useful for patients with esophageal squamous cell carcinoma. Onco Targets Ther 2014;7:1811-5. [PMID: 25336972 DOI: 10.2147/OTT.S68084] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
47 Yang L, Gao J, Zhou Y, Tao Z, He J, Yang J, Wang R, Zhang Y, Huang Y, Zhou L, Sun B. Effect of Oral Nutritional Supplements on Patients with Esophageal Cancer During Radiotherapy. Cancer Biother Radiopharm 2020. [PMID: 32833549 DOI: 10.1089/cbr.2020.3888] [Reference Citation Analysis]
48 Huerter ME, Charles EJ, Downs EA, Hu Y, Lau CL, Isbell JM, Mcmurry TL, Kozower BD. Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy. The Annals of Thoracic Surgery 2016;102:948-54. [DOI: 10.1016/j.athoracsur.2016.03.041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
49 Mallet R, Modzelewski R, Lequesne J, Mihailescu S, Decazes P, Auvray H, Benyoucef A, Di Fiore F, Vera P, Dubray B, Thureau S. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer. Radiat Oncol 2020;15:116. [PMID: 32443967 DOI: 10.1186/s13014-020-01545-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
50 Sun P, Zhang F, Chen C, An X, Li YH, Wang FH, Zhu ZH. Comparison of the prognostic values of various nutritional parameters in patients with esophageal squamous cell carcinoma from Southern China. J Thorac Dis 2013;5:484-91. [PMID: 23991306 DOI: 10.3978/j.issn.2072-1439.2013.08.38] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
51 Sheng X, Zhang H, Ge P, Chen L, Zhang S. A Retrospective Study of The Prognostic Significance of Preoperative Plasma Fibrinogen, Mean Platelet Volume, and the Neutrophil-to-Lymphocyte Ratio in Patients with Laryngeal Squamous Cell Carcinoma. Med Sci Monit 2019;25:4527-34. [PMID: 31210172 DOI: 10.12659/MSM.914426] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
52 Cong MH, Li SL, Cheng GW, Liu JY, Song CX, Deng YB, Shang WH, Yang D, Liu XH, Liu WW, Lu SY, Yu L. An Interdisciplinary Nutrition Support Team Improves Clinical and Hospitalized Outcomes of Esophageal Cancer Patients with Concurrent Chemoradiotherapy. Chin Med J (Engl) 2015;128:3003-7. [PMID: 26608978 DOI: 10.4103/0366-6999.168963] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
53 Shin HJ, Moon HS, Kang SH, Sung JK, Jeong HY, Kim SH, Lee BS, Kim JS, Yun GY. Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma: Is it a significant prognostic factor? Medicine (Baltimore) 2017;96:e9441. [PMID: 29390576 DOI: 10.1097/MD.0000000000009441] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
54 Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. [PMID: 21176210 DOI: 10.1186/1475-2891-9-69] [Cited by in Crossref: 505] [Cited by in F6Publishing: 536] [Article Influence: 42.1] [Reference Citation Analysis]
55 Vashi PG, Gupta D, Lammersfeld CA, Braun DP, Popiel B, Misra S, Brown KC. The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy. Nutr J 2013;12:118. [PMID: 23941331 DOI: 10.1186/1475-2891-12-118] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
56 Moy RH, Sabwa S, Maron SB, Shcherba M, Apollo A, Janjigian YY, Ku GY, Tew WP, Wu AJ, Jones DR, Molena D, Ilson DH, Won E. A nutritional management algorithm in older patients with locally advanced esophageal cancer. J Geriatr Oncol 2021:S1879-4068(21)00160-0. [PMID: 34393090 DOI: 10.1016/j.jgo.2021.06.012] [Reference Citation Analysis]
57 Xu YJ, Cheng JC, Lee JM, Huang PM, Huang GH, Chen CC. A Walk-and-Eat Intervention Improves Outcomes for Patients With Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy. Oncologist 2015;20:1216-22. [PMID: 26341759 DOI: 10.1634/theoncologist.2015-0178] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
58 Yoon HG, Oh D, Ahn YC, Noh JM, Pyo H, Cho WK, Song YM, Park M, Hwang NY, Sun JM, Kim HK, Zo JI, Shim YM. Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer. Cancers (Basel) 2020;12:E925. [PMID: 32290037 DOI: 10.3390/cancers12040925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
59 van Rossum PSN, Mohammad NH, Vleggaar FP, van Hillegersberg R. Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends. Nat Rev Gastroenterol Hepatol. 2018;15:235-249. [PMID: 29235549 DOI: 10.1038/nrgastro.2017.162] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
60 Tougeron D, Hamidou H, Scotté M, Di Fiore F, Antonietti M, Paillot B, Michel P. Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes. BMC Cancer. 2010;10:510. [PMID: 20868479 DOI: 10.1186/1471-2407-10-510] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
61 Bozzetti F. Nutritional support in patients with oesophageal cancer. Support Care Cancer 2010;18:41-50. [DOI: 10.1007/s00520-009-0664-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
62 Chen Z, Shao Y, Wang K, Cao W, Xiong Y, Wu R, Luo S, Xu X, He X. Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis. Onco Targets Ther. 2016;9:6701-6710. [PMID: 27822073 DOI: 10.2147/ott.s108469] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
63 Zoltan L, Farkas R, Schally AV, Pozsgai E, Papp A, Bognár L, Tornoczki T, Mangel L, Bellyei S. Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer. Pathol Oncol Res 2019;25:279-88. [PMID: 29103201 DOI: 10.1007/s12253-017-0342-z] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
64 Mariani L, Lo Vullo S, Bozzetti F; on behalf of the SCRINIO Working Group. Weight loss in cancer patients: a plea for a better awareness of the issue. Support Care Cancer 2012;20:301-9. [DOI: 10.1007/s00520-010-1075-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
65 Feng JF, Huang Y, Liu JS. Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2013;6:1605-1612. [PMID: 24403837 DOI: 10.2147/ott.s52501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 39] [Article Influence: 1.2] [Reference Citation Analysis]
66 Sato S, Kunisaki C, Suematsu H, Tanaka Y, Miyamoto H, Kosaka T, Yukawa N, Tanaka K, Sato K, Akiyama H, Endo I. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy. In Vivo 2018;32:603-10. [PMID: 29695567 DOI: 10.21873/invivo.11282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
67 Yi X, Liu Y, Zhou B, Xiang W, Deng A, Fu Y, Zhao Y, Ouyang Q, Liu Y, Sun Z, Zhang K, Li X, Zeng F, Zhou H, Chen BT. Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment. Biomedicine & Pharmacotherapy 2021;133:111013. [DOI: 10.1016/j.biopha.2020.111013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Bozzetti F. Why the oncologist should consider the nutritional status of the elderly cancer patient. Nutrition 2015;31:590-3. [DOI: 10.1016/j.nut.2014.12.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
69 Platek ME, Reid ME, Wilding GE, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck 2011;33:1561-8. [PMID: 21990220 DOI: 10.1002/hed.21640] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
70 Scholtz K, Spies CD, Mörgeli R, Eckardt R, von Dossow V, Braun S, Sehouli J, Bahra M, Stief CG, Wernecke KD, Schmidt M; PERATECS Group. Risk factors for 30-day complications after cancer surgery in geriatric patients: a secondary analysis. Acta Anaesthesiol Scand 2018;62:451-63. [PMID: 29359461 DOI: 10.1111/aas.13067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
71 Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE. Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition 2019;67-68:110539. [PMID: 31522087 DOI: 10.1016/j.nut.2019.06.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
72 Lee JS, Ahn JY, Choi KD, Song HJ, Kim YH, Lee GH, Jung HY, Ryu JS, Kim SB, Kim JH, Park SI, Cho KJ, Kim JH. Synchronous second primary cancers in patients with squamous esophageal cancer: Clinical features and survival outcome. Korean J Intern Med. 2016;31:253-259. [PMID: 26864297 DOI: 10.3904/kjim.2014.182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
73 Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Sho M. Prognostic Significance of the Prognostic Nutritional Index in Patients with Recurrent Esophageal Squamous Cell Carcinoma. Nutrition and Cancer 2018;70:467-73. [DOI: 10.1080/01635581.2018.1445771] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
74 Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 2010;116:5619-27. [PMID: 21136578 DOI: 10.1002/cncr.25745] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
75 Blais E, Vendrely V, Sargos P, Créhange G, Huguet F, Maingon P, Simon JM, Bourdais R, Ozsahin M, Bourhis J, Clément-Colmou K, Belghith B, Proudhom Briois MA, Gilliot O, Dujols JP, Peyras A, Dupin C, Riet FG, Canova CH, Huertas A, Troussier I. [Chemoradiation for oesophageal cancer: A critical review of the literature]. Cancer Radiother 2019;23:62-72. [PMID: 30639379 DOI: 10.1016/j.canrad.2018.05.003] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
76 Opstelten JL, de Wijkerslooth LR, Leenders M, Bac DJ, Brink MA, Loffeld BC, Meijnen-Bult MJ, Minderhoud IM, Verhagen MA, van Oijen MG, Siersema PD. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions. Dis Esophagus. 2017;30:1-7. [PMID: 26919349 DOI: 10.1111/dote.12478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
77 Willemsen ACH, Hoeben A, Lalisang RI, Van Helvoort A, Wesseling FWR, Hoebers F, Baijens LWJ, Schols AMWJ. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma. J Cachexia Sarcopenia Muscle 2020;11:145-59. [PMID: 31536685 DOI: 10.1002/jcsm.12487] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
78 Nasrah R, Van Der Borch C, Kanbalian M, Jagoe RT. Defining barriers to implementation of nutritional advice in patients with cachexia. J Cachexia Sarcopenia Muscle 2020;11:69-78. [PMID: 31436033 DOI: 10.1002/jcsm.12490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
79 Hollertz P, Lindblad M, Sandström P, Halldestam I, Edholm D. Outcome of microscopically non-radical oesophagectomy for oesophageal and oesophagogastric junctional cancer: nationwide cohort study. BJS Open 2021;5:zrab038. [PMID: 33972990 DOI: 10.1093/bjsopen/zrab038] [Reference Citation Analysis]
80 Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, Terlecki G, Gamian A. Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers. Clin Chem Lab Med 2008;46:359-64. [PMID: 18303990 DOI: 10.1515/CCLM.2008.089] [Cited by in Crossref: 52] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
81 Kimura J, Kunisaki C, Makino H, Oshima T, Ota M, Oba M, Takagawa R, Kosaka T, Ono HA, Akiyama H, Endo I. Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer. Dis Esophagus 2016;29:1071-80. [PMID: 26471766 DOI: 10.1111/dote.12420] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
82 Chao PC, Chuang HJ, Tsao LY, Chen PY, Hsu CF, Lin HC, Chang CY, Lin CF. The Malnutrition Universal Screening Tool (MUST) and a nutrition education program for high risk cancer patients: strategies to improve dietary intake in cancer patients. Biomedicine (Taipei) 2015;5:17. [PMID: 26264480 DOI: 10.7603/s40681-015-0017-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
83 Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Sho M. The Prognostic Significance of the Geriatric Nutritional Risk Index in Patients with Esophageal Squamous Cell Carcinoma. Nutr Cancer 2018;70:1237-45. [PMID: 30235009 DOI: 10.1080/01635581.2018.1512640] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
84 Di Fiore A, Lecleire S, Gangloff A, Rigal O, Benyoucef A, Blondin V, Sefrioui D, Quiesse M, Iwanicki-caron I, Michel P, Di Fiore F. Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer. Digestive and Liver Disease 2014;46:270-5. [DOI: 10.1016/j.dld.2013.10.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
85 Hurmuzlu M, Monge OR, Smaaland R, Viste A. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome. Dis Esophagus 2010;23:244-52. [PMID: 19664075 DOI: 10.1111/j.1442-2050.2009.00999.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
86 Kobayashi T, Teruya M, Kishiki T, Endo D, Takenaka Y, Tanaka H, Miki K, Kobayashi K, Morita K. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma. Surgery 2008;144:729-35. [PMID: 19081014 DOI: 10.1016/j.surg.2008.08.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 4.9] [Reference Citation Analysis]
87 Witham G. Nutrition and cancer: issues related to treatment and survivorship. Br J Community Nurs 2013;Suppl Nutrition:S20-4. [PMID: 24177239 DOI: 10.12968/bjcn.2013.18.sup10.s20] [Reference Citation Analysis]
88 Sun P, Zhang F, Chen C, Bi X, Yang H, An X, Wang F, Jiang W. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China. Oncotarget. 2016;7:42650-42660. [PMID: 27223088 DOI: 10.18632/oncotarget.9516] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
89 Pérez-pitarch A, Guglieri-lópez B, Nacher A, Merino V, Merino-sanjuán M. Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review. Nutrition and Cancer 2017;69:555-63. [DOI: 10.1080/01635581.2017.1299878] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
90 Jain R, Handorf E, Khare V, Blau M, Chertock Y, Hall MJ. Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants. Oncologist 2019:theoncologist. [PMID: 31748339 DOI: 10.1634/theoncologist.2019-0289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
91 Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C. Clinical Value of Nutritional Status in Cancer: What is its Impact and how it Affects Disease Progression and Prognosis? Nutr Cancer. 2017;69:1151-1176. [PMID: 29083236 DOI: 10.1080/01635581.2017.1367947] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
92 Dong J, Zhang W, Zhang T, Chen X, Zhao J, Zeng Y, Chen Y, Wei X, Lei T, Wang P, Zhao L, Wang J, Yuan Z, Song Y, Liu N, Wang K, Pang Q. Baseline nutritional status could be a predictor for radiation esophagitis in esophageal cancer patients undergoing radiotherapy. Ann Transl Med 2020;8:1148. [PMID: 33240997 DOI: 10.21037/atm-20-4078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
93 Cohen DJ, Ajani J. An expert opinion on esophageal cancer therapy. Expert Opin Pharmacother 2011;12:225-39. [PMID: 21226634 DOI: 10.1517/14656566.2010.517748] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
94 Vleggaar FP. Stent placement in esophageal cancer as a bridge to surgery. Gastrointest Endosc. 2009;70:620-622. [PMID: 19788979 DOI: 10.1016/j.gie.2009.03.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
95 Thukral A, Metz J, Hwang WT, O'Dwyer P, Plastaras J, Both S, Bar-Ad V. Toxicity data for preoperative concurrent chemoradiotherapy with oxaliplatin and continuous infusion 5-fluorouracil for locally advanced esophageal cancer. Dis Esophagus 2011;24:330-6. [PMID: 21143694 DOI: 10.1111/j.1442-2050.2010.01145.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
96 Bozzetti F. Nutritional support of the oncology patient. Critical Reviews in Oncology/Hematology 2013;87:172-200. [DOI: 10.1016/j.critrevonc.2013.03.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.0] [Reference Citation Analysis]
97 Nassri A, Zhu H, Wang DH, Ramzan Z. Serum Albumin at Diagnosis is an Independent Predictor of Early Mortality in Veteran Patients with Esophageal Cancer. Nutr Cancer. 2018;70:1246-1253. [PMID: 30235013 DOI: 10.1080/01635581.2018.1512639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
98 Furness K, Huggins CE, Hanna L, Silvers MA, Cashin P, Low L, Croagh D, Haines TP. A process and mechanism of action evaluation of the effect of early and intensive nutrition care, delivered via telephone or mobile application, on quality of life in people with upper gastrointestinal cancer: a study protocol. BMC Cancer 2018;18:1181. [PMID: 30486814 DOI: 10.1186/s12885-018-5089-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Pellen MG, Sabri S, Razack A, Gilani SQ, Jain PK. Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer. Dis Esophagus. 2012;25:48-53. [PMID: 21595778 DOI: 10.1111/j.1442-2050.2011.01206.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
100 Zhu S, Miao CW, Wang ZT, Peng L, Li B. Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma. Onco Targets Ther 2016;9:6187-93. [PMID: 27789959 DOI: 10.2147/OTT.S115011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
101 Cho CJ, Song HJ, Lee GH, Choi KD, Kim YH, Ryu JS, Kim SB, Kim JH, Park SI, Jung HY. Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer receiving multimodality therapy. Korean J Intern Med 2017;32:443-51. [PMID: 26972059 DOI: 10.3904/kjim.2015.185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
102 Ho JK, Gui B, Yoon J, Zhang Q, Manne SL, Jabbour SK. Influence of Caregiver Presence During Physician Office Visits on Patients Undergoing Chemoradiation Therapy for Esophageal Cancer. Adv Radiat Oncol 2021;6:100649. [PMID: 33912737 DOI: 10.1016/j.adro.2021.100649] [Reference Citation Analysis]
103 Duclos A, Di Fiore F, Lecleire S, Michel P. Predictive and prognostic factors in patients with an esophageal carcinoma treated with chemoradiotherapy: the key role of nutritional parameters. Gastroenterol Clin Biol 2009;33:491-2. [PMID: 19473797 DOI: 10.1016/j.gcb.2009.02.041] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Kværner AS, Minaguchi J, Yamani NE, Henriksen C, Ræder H, Paur I, Henriksen HB, Wiedswang G, Smeland S, Blomhoff R, Collins AR, Bøhn SK. DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients—A pilot study. DNA Repair 2018;63:16-24. [DOI: 10.1016/j.dnarep.2018.01.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
105 Chen Y, Zhu HP, Wang T, Sun CJ, Ge XL, Min LF, Zhang XW, Jia QQ, Yu J, Yang JQ, Allgayer H, Abba ML, Zhang XZ, Sun XC. What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis. Oncotarget 2017;8:89095-107. [PMID: 29179502 DOI: 10.18632/oncotarget.18760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
106 Hanna L, Huggins CE, Furness K, Silvers MA, Savva J, Frawley H, Croagh D, Cashin P, Low L, Bauer J, Truby H, Haines T. Effect of early and intensive nutrition care, delivered via telephone or mobile application, on quality of life in people with upper gastrointestinal cancer: study protocol of a randomised controlled trial. BMC Cancer 2018;18:707. [PMID: 29970033 DOI: 10.1186/s12885-018-4595-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
107 Tougeron D, Di Fiore F, Hamidou H, Rigal O, Paillot B, Michel P. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis. Oncology 2007;73:328-34. [PMID: 18497505 DOI: 10.1159/000134476] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
108 Sun P, Zhang F, Chen C, Ren C, Bi XW, Yang H, An X, Wang FH, Jiang WQ. Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2016;9:6389-97. [PMID: 27799787 DOI: 10.2147/OTT.S111843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
109 Ellidag HY, Bulbuller N, Eren E, Abusoglu S, Akgol E, Cetiner M, Yılmaz N. Ischemia-modified albumin: could it be a new oxidative stress biomarker for colorectal carcinoma? Gut Liver 2013;7:675-80. [PMID: 24312708 DOI: 10.5009/gnl.2013.7.6.675] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]